首页 > 用药指导 > 文章详情

Baricitinib(巴瑞替尼)的作用功效与副作用

发布时间:2023-12-25 08:22:20 阅读:1101 来源:问药网
分享至

分享到微信朋友圈

×

打开微信,点击底部的“发现”,

使用“扫一扫”即可将网页分享至朋友圈。

巴瑞替尼片

巴瑞替尼片 生产厂家:孟加拉方圆制药Square Pharmaceuticals 功能主治:JAK1/2抑制剂,用于多种炎症性疾病和自身免疫性疾病 用法用量:用法用量  1、类风湿性关节炎  OLUMIANT的推荐剂量为每日1次口服2mg,餐前餐后都可。  OLUMIANT可以单独使用,也可以与甲氨蝶呤或其他非生物dmard联合使用。  2、COVID-19(新冠病毒)  成人OLUMIANT的推荐剂量为每日一次口服4mg,餐前餐后都可,持续14天或直到出院,以先发生者为准。  3、斑秃  OLUMIANT的推荐剂量是2mg,每天一次口服,餐前餐后都可。  如果对治疗的反应不充分,增加到每天一次4mg。  对于几乎完全或完全的头皮脱发,睫毛或眉毛有或没有大量脱发的患者,考虑每天一次4mg治疗,伴餐前餐后都可。  一旦患者对4mg的治疗产生了充分的反应,将剂量减少到2mg,每天一次。  对于无法吞下整片药片的患者,可以考虑另一种给药方式:  1、口服分散  2、胃造口管(G管)  3、鼻胃管(NG管)或口胃管(OG管)
查看详情

Baricitinib(巴瑞替尼)的作用功效与副作用,Baricitinib(Baricitinib)常见副作用有:1、严重感染,如肺炎、带状疱疹和尿路感染;2、死亡率,50岁以上及有心血管疾病的患者有更高的全因死亡率;3、恶性肿瘤和淋巴增生性疾病;4、重大心血管不良事件;5、血栓形成;6、会出现过敏反应;7、胃肠道穿孔;8、可能会对胎儿造成损害。

Baricitinib (巴瑞替尼) is a medication that has shown promise in the treatment of several conditions, including rheumatoid arthritis, COVID-19, and alopecia areata. It is important to note that Baricitinib should only be used under the supervision of a healthcare professional. In this article, we will explore the effects, benefits, and potential side effects of Baricitinib.

1. Baricitinib's Role in Rheumatoid Arthritis Treatment:

Rheumatoid arthritis (RA) is an autoimmune disease that causes joint inflammation, pain, and stiffness. Baricitinib is a targeted synthetic disease-modifying antirheumatic drug (DMARD) that works by selectively inhibiting Janus kinase (JAK) enzymes. By acting on JAK enzymes, Baricitinib helps reduce the activity of the immune system, thereby alleviating the symptoms of RA. Clinical trials have shown that Baricitinib can effectively improve joint function and reduce the progression of joint damage in patients with moderate to severe RA.

2. Baricitinib's Potential Role in COVID-19 Treatment:

In the midst of the COVID-19 pandemic, Baricitinib emerged as a potential treatment option. Research has indicated that Baricitinib may have antiviral and anti-inflammatory properties that could be beneficial in managing COVID-19. The drug's ability to inhibit JAK enzymes may help reduce the excessive immune response and the associated inflammation seen in severe cases of COVID-19. Combining Baricitinib with other antiviral drugs, such as remdesivir, has shown promising results in reducing the duration of hospitalization and accelerating recovery. However, it is important to note that Baricitinib should not be used for the treatment of COVID-19 without proper medical guidance.

3. Baricitinib in the Treatment of Alopecia Areata:

Alopecia areata is an autoimmune condition characterized by hair loss, typically in patches. It occurs when the immune system mistakenly attacks hair follicles. Studies have suggested that Baricitinib may be effective in treating moderate to severe cases of alopecia areata. The drug's immunomodulatory properties can target the immune cells responsible for attacking hair follicles, potentially promoting hair regrowth. However, further research is needed to establish the safety and efficacy of Baricitinib for this specific condition.

4. Potential Side Effects of Baricitinib:

As with any medication, Baricitinib can have side effects. Common side effects may include upper respiratory tract infections, headache, and increased cholesterol levels. Rare but serious side effects may include blood clotting disorders, serious infections, and changes in liver function. Patients taking Baricitinib should be closely monitored by their healthcare provider to detect and manage any potential adverse effects.

In conclusion, Baricitinib has shown promise in the treatment of rheumatoid arthritis, potential utility in managing COVID-19, and potential benefits for alopecia areata. However, it is crucial to recognize that Baricitinib should only be used under the supervision of a healthcare professional who can carefully assess the benefits and risks for each individual patient.